Literature DB >> 9822983

Plasma substance-P and substance-K and gonadal steroids in relation to the gonadotropin surge in normal human reproductive cycles.

D L Mohyi1, B Kerdelhué, V Lenoir, P Kolm, H W Jones, G S Jones.   

Abstract

PURPOSE: This study was designed to examine changes in peripheral plasma substance-P and -K levels, their association with follicle-stimulating hormone and luteinizing hormone release in normal reproductive cycles in humans, and their correlation with plasma estradiol and progesterone.
METHODS: Fourteen healthy, normally menstruating women underwent daily blood sampling (cycle day 4, 4-14 days) for measurement of estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone, substances-P and -K, and daily transvaginal ultrasounds assessing follicular growth and documentation of ovulation.
RESULTS: Estradiol peaked on day 13, luteinizing hormone and follicle-stimulating hormone peaked on day 14, and progesterone began an exponential increase on about day 13.
CONCLUSIONS: In contrast to other experimental designs using in vitro or in vivo rat or monkey tissue, peripheral levels of substances-P (P = 0.8391) and -K (P = 0.3205) reflected no modulation related to midcycle gonadotropin release in cycling woman.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822983      PMCID: PMC3454922          DOI: 10.1023/a:1022534204239

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  23 in total

1.  The functional changes of the pituitary gonadotrophs during the menstrual cycle.

Authors:  C F Wang; B L Lasley; A Lein; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1976-04       Impact factor: 5.958

Review 2.  The luteinized unruptured follicle and other ovulatory dysfunctions.

Authors:  E Katz
Journal:  Fertil Steril       Date:  1988-12       Impact factor: 7.329

3.  Pulsatile patterns of gonadotropin release in subjects with and without ovarian function.

Authors:  S S Yen; C C Tsai; F Naftolin; G Vandenberg; L Ajabor
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

4.  Priming effect of luteinizing hormone releasing factor: in-vitro and in-vivo evidence consistent with its dependence upon protein and RNA synthesis.

Authors:  A J Pickering; G Fink
Journal:  J Endocrinol       Date:  1976-06       Impact factor: 4.286

5.  Intercycle serum follicle-stimulating hormone elevations: significance in recruitment and selection of the dominant follicle and assessment of corpus luteum normalcy.

Authors:  G diZerega; W E Nixon; G D Hodgen
Journal:  J Clin Endocrinol Metab       Date:  1980-06       Impact factor: 5.958

6.  Estradiol potentiation of gonadotropin-releasing hormone responsiveness in the anterior pituitary is mediated by an increase in gonadotropin-releasing hormone receptors.

Authors:  M Menon; H Peegel; V Katta
Journal:  Am J Obstet Gynecol       Date:  1985-02-15       Impact factor: 8.661

7.  In-vivo inhibition of the preovulatory LH surge by substance P and in-vitro modulation of gonadotrophin-releasing hormone-induced LH release by substance P, oestradiol and progesterone in the female rat.

Authors:  T Battmann; S Mĕlik Parsadaniantz; B Jeanjean; B Kerdelhué
Journal:  J Endocrinol       Date:  1991-08       Impact factor: 4.286

8.  Effects of tachykinins on luteinizing hormone release in female rats: potent inhibitory action of neuropeptide K.

Authors:  A Sahu; S P Kalra
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

9.  Neurokinin A levels in the hypothalamus of rats and mice: effects of castration, gonadal steroids and expression of heterologous growth hormone genes.

Authors:  L Debeljuk; P Ghosh; A Bartke
Journal:  Brain Res Bull       Date:  1990-11       Impact factor: 4.077

10.  Immunoreactive substance P and neurokinin A in the hypothalamus and anterior pituitary gland of Siberian and Syrian hamsters and of rats.

Authors:  L Debeljuk; A Bartke
Journal:  J Reprod Fertil       Date:  1994-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.